How to open a pharmacy in Australia

A pharmacy is a hybrid business. One half behaves like healthcare — script volume driven by an ageing population, GP referrals and the PBS — the other half like retail, with front-of-shop stock, margin and foot traffic. On top of this sits something few other retail or medical formats carry: a federal approval gate that decides whether its main offering, PBS medicines, can actually be dispensed at any given location. Getting a pharmacy business right means reading the local market to determine whether the dispensary and retail sides can together support a viable business, and clearing the approval.

The demand foundations are structural. Australia's population is ageing, and older residents fill far more scripts than working-age adults — retirement age GP use averages {GP_VISIT_RATE_65_PLUS}, and every one of those visits tends to generate a prescription. With {NATIONAL_POP_65_PLUS} Australians already aged 65+ ({NATIONAL_POP_65_PCT} of the population) and that share steadily rising, the script-demand floor lifts every year. Supply, by contrast, is structurally constrained: the Location Rules impact where new PBS dispensing pharmacies can open, and well-located operators enjoy predictable returns as competitors cannot simply open next door.

Although pharmacies are often co-located with conventional retailers—and may look similar from a leasing perspective—their underlying business model is markedly different. Demand is underpinned by the PBS, new competition is constrained by pharmacy location rules, staffing requires specialised qualifications, and an ageing population provides a strong long-term demand driver. These characteristics can make a well-located pharmacy a resilient and enduring business. However, the cost of misjudging local demand can be substantial once a business has committed to premises, specialised staff and inventory. However, the Location Rules do not eliminate competitive risk: new developments, pharmacy relocations and changing customer flows can materially reshape a local market.

Scale of the sector

AreaSearch tracks {PHARMACY_LOCATION_COUNT} pharmacy locations in total, or roughly one for every {POP_PER_PHARMACY_AUS} residents. The network is large and stable, {SECTOR_NETWORK_HISTORY}, with demand driven by the needs of local residents and proximity to GPs, medical centres, hospitals and aged-care facilities. An estimated {PBS_TOTAL_SCRIPTS} PBS scripts are filled per year — {PBS_SCRIPTS_PER_GP} per GP attendance and {PBS_SCRIPTS_P100_ALL} per 100 people — amounting to {PBS_TOTAL_BENEFITS} in PBS benefit expenditure. The vast majority of pharmacy locations are PBS approved. Those which are not, such as compounding, private-script and cannabis pharmacies, are bound to a private-only revenue model.

A PBS-backed demand floor

Most of a pharmacy's script volume flows through the Pharmaceutical Benefits Scheme, and that demand is remarkably insensitive to the economy — people fill prescriptions regardless of the cycle. With {BULK_BILLING_RATE_NATIONAL} of GP attendances bulk-billed and every one a potential script, underlying demand is steadier than in almost any pure-retail format. The whole system is funded through the {CPA_CURRENT}, the agreement between the Commonwealth and the profession that sets dispensing remuneration and the Location Rules the sector runs on: {CPA_VALUE}, running {CPA_TERM}.

The structural tailwind — ageing

The 65+ cohort is the engine of script demand. Older residents visit a GP at {GP_VISIT_RATE_65_PLUS} versus far fewer for working-age adults, and each chronic condition generates repeat prescriptions for years. Already {NATIONAL_POP_65_PCT} of the population is over 65 ({NATIONAL_POP_65_PLUS} people), and the fastest-growing cohort of all is the 80+ group, where medication use steps up sharply. More older people, more conditions per person, more scripts per person — the demand curve only steepens over a typical lease term.

The headwind — 60-day prescriptions

The counterweight is pressure on dispensing frequency. {DISPENSING_60DAY} means eligible patients with stable, ongoing conditions now collect two months of supply for one dispensing fee instead of one — compressing dispensing-fee revenue on the affected scripts and reducing foot-traffic. It is fully rolled out and priced into the market in {LATEST_REFRESH_DATE}, and makes a front-of-shop stream and a genuinely undersupplied catchment matter more than before.

The offsetting tailwind — scope of practice

Pushing the other way is a widening clinical role. {SCOPE_EXPANSION}. The policy direction is clear: services initially trialled for vaccinations, uncomplicated UTIs and hormonal contraception are being made permanent and extended to a broader range of common conditions. Although still modest relative to conventional dispensing, this creates a credible growth pathway through consultation and service revenue, diversifies pharmacy income and gives customers additional reasons to visit between prescription collections.

Cyclical position

Essential health-retail is resilient, but the macro backdrop still matters for financing and rents. The RBA cash rate sits at {CASH_RATE_CURRENT} ({CASH_RATE_DATE}), national unemployment holds at {AUS_UNEMP_CURRENT} ({AUS_UNEMP_DATE}), and health-related prices have risen {CPIHEALTH_12MO_AUS} over the past year. Population growth remains a structural tailwind, with annual net overseas migration adding {AUS_NOM_LATEST} ({AUS_NOM_DATE}) — every new household needs a pharmacy within reach. Steady employment and sustained population growth support demand while elevated rates and input costs are important to consider when stress testing an opportunity.

AreaSearch's tools work for two different situations. The path you take depends on where you're starting from:

The tools are described in detail below. For most users, the area profile is the right starting point — it's free, covers any area in Australia, and gives you age, health and local economic context in one click.

Co-location & proximity

For a dispensing pharmacy, proximity to prescribing GPs is not just convenient — it is written into the Location Rules and heavily influences the approval process. The doctor writes the prescription and the patient fills it at the nearest convenient pharmacy, so a pharmacy across the forecourt from a busy GP clinic captures a very different flow than one a few hundred metres away. Nationally the average resident is about {NATIONAL_GP_MEAN_DIST} from their nearest GP, with roughly {POP_PER_GP_AUS} residents per GP ({GP_COUNT_AUS} GPs), and {NATIONAL_PHARMACY_MEAN_DIST} from their nearest pharmacy.

Local demand profile

PBS utilisation by category

Projections

The competitive environment

Each site's competitive position is ranked against every pharmacy in the country.

Effective Population (x) vs. Distance to Nearest Competitor (y)

Each dot is an Australian pharmacy plotted by its competition-adjusted effective population and distance to its nearest competitor.

Incoming supply — the DA pipeline

Supply-and-demand ratios describe what is already operating. A catchment that looks undersupplied today can be saturated within a couple of years if approved developments are in the pipeline — and for pharmacy, a new competitor landing inside your 1.5 km radius can end your s90 case before you open. Council DAs are where forward supply shows up: approved but not yet built, applications under assessment, and clusters of lodgements that signal other operators have spotted the same gap. AreaSearch scans the DA register within the catchment radius and tracks the trailing approvals trend, so you can see whether the pipeline is accelerating or cooling.

You have found a catchment with the right demographic profile and a genuine supply gap. Before the economics, a pharmacy faces a question no other retail or medical format does: is this site even approvable?

The approval maze — who actually decides

Almost everyone new to the sector conflates two completely separate approvals.

Statutory zoning, development controls and lot boundaries on the map — click any lot for its zoning code and controls.

• State/territory registration grants the right to operate a pharmacy business at premises — it governs who may own a pharmacy and the standards the premises must meet. It is issued by a state authority and the rules vary by jurisdiction (see the table below).
• Federal Section 90 approval, under the {PHARMACY_APPROVAL_ACT}, grants {S90_APPROVAL_DEF}. It is decided by the {HEALTH_DEPT_NAME} on the recommendation of the {ACPA_NAME}.

The two are independent. A pharmacy can legally operate without s90 — patients simply pay full private prices, the model behind some compounding, private-script and cannabis pharmacies — but without s90 it cannot dispense PBS medicines or claim Commonwealth reimbursement, which is where the volume is. The approval pathway itself is straightforward once you see it: {APPROVAL_PATHWAY}. The {ACPA_NAME} {ACPA_ROLE}, and it meets {ACPA_MEETING_CADENCE}.

Two more bodies complete the map, and naming them resolves the most common confusion. {GUILD_APPROVAL_CLARIFIER} — so despite its prominence it does not sit in your approval chain at all. Separately, {AHPRA_ROLE}, and {PPA_ROLE}. Registration of the pharmacist, approval of the premises, and payment of program claims are three different things handled by three different bodies.

The Location Rules

The federal layer is uniform nationwide, and it hangs off one instrument: the {LR_INSTRUMENT}. These are the distance and proximity thresholds that decide whether a new pharmacy can win s90 at a given site — and they map exactly onto the metrics AreaSearch computes (nearest-competitor distance, GP proximity, supermarket proximity).

The complete set of items, exclusions and relocation rules is in the {LR_HANDBOOK} — read it before you rely on any single threshold, because exclusions and definitions do the heavy lifting. The point for site selection is simple: measure the straight-line distance to the nearest approved pharmacy, the GP, and the supermarket first. If this check fails, the application faces a much harder path, regardless of demographic strength.

State by state — ownership & registration

Where the federal layer is uniform, the state layer is where the hurdles genuinely vary: who may hold an interest in a pharmacy, how many pharmacies one owner may hold, permitted corporate structures, and which authority registers the premises. No single government page consolidates this, so the table below is high-value — but treat it as a starting map and confirm each cell with the relevant authority before you commit.

Queensland is mid-transition. {OWN_QLD_TRANSITION}. If you are looking at Queensland, treat this row as time-sensitive and confirm the current position directly with the Council.

What evidence helps

An s90 application is won on evidence, and the evidence a Location-Rules assessment weighs is exactly the output of the custom catchment described in Section 02: the competition-adjusted effective population, the measured straight-line distances to the nearest approved pharmacy, the full-time GP and the qualifying supermarket, and the incoming development pipeline. Packaged together, that is the needs-assessment evidence pack — the difference between asserting a catchment is undersupplied and demonstrating it.

Two-stream economics

Once a site is approvable, the business is a blend of two very different revenue streams. The dispensary is the demand-driven portion — typically around {DISPENSARY_REVENUE_PCT} of revenue — earning a regulated margin on PBS and private scripts. Front-of-shop is the retail portion — around {FRONT_OF_SHOP_PCT} — earning a merchandise margin on health, beauty and convenience lines. They behave differently: the dispensary is steadier but margin-compressed (the 60-day change bites here), while front-of-shop is more discretionary but higher-margin and more responsive to foot traffic and merchandising. Resilient pharmacies generally provide both.

Industry benchmark data (from the profession's published Guild Digest ranges) gives a feel for a typical established pharmacy:

Lease, rent and physical factors

Rent has to stay in proportion to turnover. Occupancy cost — rent plus outgoings — running at {PHARMACY_RENT_PCT} is the benchmark; drift well above it and a dip in script volume can tip the business into loss. That ratio is the fastest sanity-check on a rent quote against the catchment's realistic throughput. Beyond rent, the physical factors that move a pharmacy are convenience-driven: co-location with or immediate proximity to a busy GP clinic, easy parking and pram/wheelchair access for older and less-mobile patients, visibility and walk-in foot traffic, and a supermarket anchor pulling routine trips past the door. A primary catchment is generally tight, spanning {PHARMACY_CATCHMENT_RADIUS}, so metres matter more here than in most retail formats.

{EXAMPLE_HIGH_NAME} and {EXAMPLE_LOW_NAME} are two {PAIR_ADJACENCY}SA4 regions in Greater {PAIR_METRO}. On residents per pharmacy — {EXAMPLE_HIGH_POP_PER_PHARMACY} against {EXAMPLE_LOW_POP_PER_PHARMACY} — one looks markedly more stretched than the other.

A region is a large area, and pharmacies are not spread evenly across it, and PBS volumes are attributed to the patient’s home address rather than the dispensing pharmacy, so a region with a large daytime workforce dispenses more than this figure shows. Two illustrative sites — one in each region — show what the numbers look like at street level, where the Location Rules bite.

Site-level analysis — market and approval geometry

A pharmacy’s catchment is the residents within a short drive, whichever boundary they fall in — and its approvability is decided by the straight-line distances around it. The two sites below are illustrative, not real addresses, and each is judged on both market and approval geometry.

Sources: ABS · RBA · Department of Health, Disability and Ageing (s90 / ACPA / Location Rules / Applicant's Handbook) · Federal Register of Legislation · PBS · Pharmacy Board of Australia (Ahpra) · Pharmacy Programs Administrator · Pharmacy Guild of Australia · state & territory pharmacy authorities · AreaSearch. Updated {LATEST_REFRESH_DATE}. This article is a preliminary scoping resource. Make your own enquiries and seek independent professional advice before acting on any information here.